GLP-1 THERAPY PROGRAM Your carefully designed Program is designed and adjusted as lab results and progress are reviewed to ensure optimal results
The Biggest ADA 2026 Obesity Drug Breakthroughs ADA 2026 delivered a massive wave of obesity and diabetes data, and in this episode of On The Pen, Dave Knapp (@manonthemounjaro) sits down with Jen (@JcanNuSH) to break down the molecules, clinical trials, weight loss results, and safety signals that could define the next generation of obesity and diabetes medicine
doi: 10.1111/dom.15829 19 JensenSBKBlondMBSandsdalRMOlsenLMJuhlCRLundgrenJRet al
Exendin-4 is in many ways similar to the human hormone GLP-1, which increases insulin production in the pancreas
The pills can be taken continuously until reaching the desired weight, with no need for breaks
Goes away for most people